Omeros (OMER) Gross Profit (2014 - 2026)

Omeros (OMER) posted Gross Profit of $9.3 million for Q1 2026, up 108.49% sequentially from -$109.6 million in Q4 2021.

Analysis

Omeros (OMER) Gross Profit (2014 - 2026) Analysis & Trends

Omeros has reported Gross Profit for 9 years, with the latest figure at $9.3 million in Q1 2026.

Quarterly Gross Profit changed N/A year-over-year to $9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$70.6 million (down 37.28% YoY) and the FY2021 annual result came in at $80.1 million, up 9.87% from the prior year.
Gross Profit climbed to $9.3 million in Q1 2026 per OMER's latest filing, from -$109.6 million in the prior quarter.
Over five years, Gross Profit peaked at $9.3 million in Q1 2026 and troughed at $9.3 million in Q1 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.77 Bn	130.92 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.51 Bn	77.52 Bn	3.93 Bn
3	Argenx Se	63.51 Bn	58.32 Bn	1.37 Bn
4	Moderna	58.20 Bn	53.06 Bn	52.00 Mn
5	Revolution Medicines	44.04 Bn	44.04 Bn	-
6	BeOne Medicines	39.99 Bn	34.89 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.45 Bn	32.14 Bn	992.69 Mn
8	Royalty Pharma	28.40 Bn	27.56 Bn	-
9	Insmed	27.44 Bn	26.28 Bn	358.27 Mn
10	Omeros	1.37 Bn	1.37 Bn	27.73 Mn

Historic Data

Download Data